Anxiety in women 'at risk' of developing breast cancer
1996

Anxiety in Women at Risk of Breast Cancer

Sample size: 272 publication Evidence: moderate

Author Information

Author(s): K Thirlaway, L Fallowfield, H Nunnerley, T Powles

Primary Institution: Royal Marsden Hospital

Hypothesis

Do family history clinics alleviate or exacerbate anxiety in women at high risk of developing breast cancer?

Conclusion

Specialist clinics do not see the most anxious women, and participation in tamoxifen prevention programs does not increase anxiety.

Supporting Evidence

  • 47.5% of tamoxifen trial participants recognized the general population risk of breast cancer as 1 in 12.
  • Women with a family history not attending clinics had higher anxiety scores than those participating in the tamoxifen trial.
  • Understanding of general population risk explained only 3% of the variance in anxiety.

Takeaway

This study looked at women worried about breast cancer and found that going to special clinics doesn't make them more anxious.

Methodology

The study compared anxiety levels in women participating in a tamoxifen trial with those not attending specialist clinics, using standardized anxiety questionnaires.

Potential Biases

Women with higher anxiety may avoid specialist clinics, potentially skewing results.

Limitations

The study may not fully account for all factors influencing anxiety, and the social class data were unreliable.

Participant Demographics

Women aged 50 or more, with a family history of breast cancer, recruited from both a specialist clinic and a national screening program.

Statistical Information

P-Value

0.005

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication